Estudo randomizado | Adição de metformina à terapia padrão não melhora os desfechos em pacientes com câncer de mama.
26 Mai, 2022 | 13:31hEffect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial – JAMA (gratuito por tempo limitado)
Editorial: Who Will Benefit From Metformin? – JAMA Oncology
Comunicado de imprensa: Common diabetes drug not effective against early-stage breast cancer, landmark trial reveals – Lunenfeld-Tanenbaum Research Institute